Skip to main content
. 2022 Oct 4;261(2):409–425. doi: 10.1007/s00417-022-05837-w

Fig. 2.

Fig. 2

Effects of intravitreal application of vehicle ascorbic acid (green, n = 11 eyes), atropine + spiperone (orange, n = 11 eyes), atropine (red, n = 7 eyes), and no injection (yellow, n = 6 eyes) on dopamine and DOPAC content, 2 h after injections. A There were no significant effects on dopamine content in vitreous and retina in spiperone + atropine–injected eyes, compared to atropine alone, but dopamine was clearly increased in the choroid in atropine + spiperone–injected eyes. B Atropine + spiperone injections reduced DOPAC content in the vitreous, compared to atropine alone, or to untreated eyes with no injection at all or to eyes injected with ascorbic acid (green bar). In the retina, DOPAC was elevated both after ascorbic acid and atropine + spiperone injections, compared to atropine alone and non-injected eyes. Two-tailed unpaired Student’s t-tests; *p < 0.05, **p < 0.01. Colors of asterisks match the color of the data column for comparison